Details of the Drug

General Information of Drug (ID: DMN279C)

Drug Name

Malaria DNA vaccine

Indication

Disease Entry	ICD 11	Status	REF
Malaria	1F40-1F45	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical trial in healthy malaria-na ve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. Hum Vaccin Immunother. 2012 November 1; 8(11): 1564-1584.